Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Progress Update on the Epidemiology of COVID-19 Variants and the Assessment Status of Developed Vaccines

    Katharigatta N. Venugopala1,2★★ Corresponding author

    1. 1Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban, South Africa.
    2. 2Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.

    CORRESPONDENCE

    Katharigatta N. Venugopala

    Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban 4001, South Africa; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 36362, Saudi Arabia.

    katharigattav@dut.ac.za

    Volume 13, Issue 3 · pp. 293–299 · PUBLISHED 2022 · DOI: 10.1177/0976500X221138393

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread rapidly and diffused to more than 180 countries at varying severities. This pandemic has accounted for increased mortality and morbidity in developed as well as developing nations. The WHO has announced that there is a persistent need for the evaluation of the COVID-19 vaccine effectiveness (VE) against major outcomes, which include severe diseases, symptomatic COVID-19, and mortalities related to COVID-19. Therefore, mass vaccination programs using vaccines of high effectiveness are among the strategies that have been used by governments worldwide to impede the COVID-19 pandemic transmission. In this regard, massive efforts were made by governments, scientists, biomedical researchers, and healthcare professionals leading to the successful development of various vaccines to bring this pandemic under control. This editorial aims to shed light on the epidemiological status of COVID-19 variants, namely, Delta, Omicron, and Deltacron variants as well as discuss the effectiveness of the currently available COVID-19 vaccines.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Venugopala, K. N. (2022). Progress Update on the Epidemiology of COVID-19 Variants and the Assessment Status of Developed Vaccines. Journal of Pharmacology and Pharmacotherapeutics, 13(3), 293–299. https://doi.org/10.1177/0976500X221138393